Home

Part of our AI Trading ecosystem

AI Trading Tool

The main AI trading tool page

AI Stock Analysis

4,600+ stocks analyzed

AI Stock Picks

Daily AI-generated picks

AI Stock Picker

Scan the universe for ideas

Stock Recommendations

Ranked AI research ideas

AI Trading Signals

Real-time momentum alerts

AI Stock Screener

Scan 4,600+ stocks live

Best AI Trading Tools

#1 pick: Stockinhood

How AI Trading Works

The technology explained

AI Stock Predictions

Multi-timeframe targets

$0.02

Current Price

22.99M

Market Cap

0.8

P/E Ratio

$0.2433

52W High

$0.003

52W Low

Company Profile

CEO

N/A

Employees

143

Year Founded

1974

Headquarters

Italy

Sector / Industry

Industrials · Specialty Industrial Machinery

Key Statistics

Market Cap

22.99M

Today's High

$0.02

Today's Low

$0.02

Open

$0.02

Previous Close

$0.02

52-Week High

$0.24

52-Week Low

$0.00

Today's Volume

46,439,477

Avg. Volume

24,000,000

Overnight Volume

N/A

Shares Outstanding

1.25B

P/E Ratio

0.85

EPS

$-0.01

Beta

0.23

Dividend Yield

0.00%

Live market stats are a premium feature

These stats are from a cached snapshot. Unlock real-time data with lifetime access — $19.99.

Earnings History

Quarterly expected vs. actual performance

Q3 20262026-11-13
Missed -50%
EPS Est.-0.00
EPS Actual-0.00
Rev. Est.$5.8M
Rev. Actual$5.6M
Q2 20262026-08-12
Missed -33%
EPS Est.-0.00
EPS Actual-0.00
Rev. Est.$6.0M
Rev. Actual$5.9M
Q1 20262026-05-15
Beat 0%
EPS Est.-0.00
EPS Actual-0.00
Rev. Est.$6.1M
Rev. Actual$6.0M
Q4 20252026-02-20
Missed -25%
EPS Est.-0.00
EPS Actual-0.01
Rev. Est.$5.9M
Rev. Actual$5.8M

Earnings data is AI-compiled from public sources and may be delayed or approximate. Not financial advice.

Historical Price Chart

Price History

Chart data unavailable

AI Price Targets

Fidia S.p.A. (BIT:FDA) is currently trading as a micro-cap industrial machinery stock with high volatility. The stock has experienced significant fluctuations, and while it shows a recent recovery from its 52-week lows, the company's financial health remains challenged by negative net income and high debt-to-equity concerns. The neutral signal reflects the lack of clear institutional analyst coverage and the speculative nature of the current price action. Short-term price targets are based on technical consolidation near current levels, while long-term upside is contingent on operational restructuring and potential improvements in industrial demand. Investors should exercise extreme caution due to the low liquidity and high beta profile.

7-Day Target

$0.02

+0.0%

30-Day Target

$0.02

+0.1%

6-Month Target

$0.02

+0.1%

AI Confidence

65%

Risk Level

High

0

Bull Case

N/A - Regulatory bodies do not have equity valuations or investor-focused growth metrics as they are government entities.

Bear Case

N/A - Regulatory bodies do not have equity valuations or investor-focused growth metrics as they are government entities.

Key Catalysts

  • PDUFA (Prescription Drug User Fee Act) reauthorization cycles
  • Implementation of new regulatory frameworks for novel therapies
  • Congressional appropriations for public health infrastructure
  • Major shifts in drug safety guidance and public health policy

Key Risks

  • •Congressional budget sequestration affecting operational capacity
  • •Political pressure influencing scientific approval processes
  • •Resource constraints leading to significant drug approval backlogs
  • •Complexity of regulating emerging technologies like AI in medicine

Company Overview

FDA (Food and Drug Administration) is not a publicly traded company, but rather a federal agency within the U.S. Department of Health and Human Services. It is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, and the nation's food supply.

Take this research further — free

Open FDA in the full AI tools and run your own analysis: live charts, 7-day to 6-month targets, and risk checks. 15 minutes free, no card required.

Rather have it all, permanently?

30-day money-back guarantee • Secure payment by Square

FDA Stock FAQ

What is the AI analysis for FDA stock?

Stockinhood's AI generates multi-timeframe price targets for FDA (Fidia S.p.A.), including 7-day, 30-day, and 6-month outlooks based on market data, technical indicators, and news sentiment. These estimates are for informational purposes only and do not constitute financial advice.

Is FDA stock a good investment?

Our AI assigns a sentiment signal (Bullish, Bearish, or Neutral) to FDA based on multiple factors including price trends, momentum, and market conditions. The current AI signal is Neutral. This is AI-generated research, not financial advice — always consult a licensed advisor before investing.

What is the price target for FDA?

The AI-generated price target for FDA is based on multi-timeframe analysis and represents a hypothetical scenario, not a guarantee. The current price is $0.02. Price targets are educational estimates and should not be relied upon for investment decisions.

What are the risks of investing in FDA?

Congressional budget sequestration affecting operational capacity Political pressure influencing scientific approval processes Resource constraints leading to significant drug approval backlogs Complexity of regulating emerging technologies like AI in medicine All risk analysis is informational only and not financial advice.

What sector is FDA in?

Fidia S.p.A. (FDA) operates in the Industrials sector, specifically the Specialty Industrial Machinery industry. This classification helps investors understand the company's business focus and compare it with peers in the same sector.